Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol
[摘要]
[发布日期] 2022-12-23 [发布机构]
[效力级别] [学科分类]
[关键词] Kawasaki disease;Corticosteroids;Coronary artery aneurysms [时效性]
